MedTrace Logo

Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa

NCT04217538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2020-01-03

No results posted yet for this study

Summary

Hereditary Epidermolysis Bullosa (EBH) are rare dermatologic diseases characterized by cutaneous and mucosa fragility. Oral manifestations of few small cohort have been published. The main objective of this multicentric cohort study first in Europe was to report the oral status of these patients that were consulted in the MRDRC of this disease in Nice (France), Toulouse (France) and Louvain (Belgium). Then a correlation between the oral characteristics and the EBH type will be made, in order to facilitate the management of patient care and the prevention program that can be established to improve their oral health.

Conditions

  • Epidermolysis Bullosa

Interventions

OTHER

clinical exam

clinical oral examination

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Eligibility

Min Age
7 Months
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-04
Primary Completion
2019-12-11
Completion
2019-12-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04217538 on ClinicalTrials.gov